Allogene Therapeutics
ALLO
$2.97
Share price
1.71%
Change (1 day)
-44.49%
Change (1 year)
Categories
Allogene Therapeutics (ALLO) - Net assets
Net assets on the balance sheet as of December 2023 : $0.51 B
According to Allogene Therapeutics
's latest financial reports the company has $0.51 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Allogene Therapeutics - Net assets on balance sheet (from 2018 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.66 B | -27.34% |
| 2021-12-31 | $0.91 B | -15.12% |
| 2020-12-31 | $1.07 B | 71.63% |
| 2019-12-31 | $0.62 B | -10.54% |
| 2018-12-31 | $0.70 B | -35158300% |
| 2017-12-31 | $-0.01 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.22 B | -56.25% | 🇺🇸 USA |